Cefazolin Injection, Powder, For Solution
Product Images NDC 0781-3451

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 0781-3451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefazolin Vial 01

Chemical structure of the active ingredient Cefazolin. The diagram depicts the detailed molecular structure, including the beta-lactam ring and various functional groups characteristic of Cefazolin.*

FDA Label Image

Cefazolin Vial 02

The label is for Cefazolin for Injection, USP 500 mg per vial, an injection powder for solution by Sandoz Inc. The package contains 10 vials of 500 mg each. It is for intramuscular or intravenous use and is sterile. Instructions include storage guidelines and usage notes, with emphasis on protection from light.*

FDA Label Image

Cefazolin Vial 03

Packaging label for Cefazolin for Injection, USP 1 gram per vial. The label shows the product name, strength, dosage form as powder for injection, and route of administration as IM or IV use. It indicates a package of 25 x 1 g vials and includes storage instructions, manufacturer Sandoz Inc, and barcode. The label emphasizes protecting from light and sterile contents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.